Jianfei Huang

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

Disease markers

Oxidative medicine and cellular longevity

Cellular & molecular biology letters

Current medicinal chemistry

Affiliated Hospital of Nantong University

Nantong University Affiliated Hospital (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Affiliated Hospital of Nantong University

China

director :: Clinical Bio-bank

Affiliated Hospital of Nantong University

China

Deputy chief physician, deputy director :: pathology

Affiliated Hospital of Nantong University Dec 01 1997

China

Dr :: Pathology

Affiliated Hospital of Nantong University

China

postdoctoral :: Surgery

American Cancer Treatment Center

United States

visiting associate professor :: pathology

Education History

Nantong University Affiliated Hospital May 28 1974

China

PHD :: Pathology

Nanjing Medical University

China

PHD :: Pathology

Nantong University

China

MSC :: Pathology

Nantong Medical College

China

BSC

Publications

Lei Yang, Jiawen Shi, Mingyang Zhong, Pingping Sun, Xiaojing Zhang, Zhengyi Lian, Hang Yin, Lijun Xu, Guyin He, Haiyan Xu, Han Wu, Ziheng Wang, Kai Miao, Jianfei Huang
NXPH4 mediated by m 5 C contributes to the malignant characteristics of colorectal cancer via inhibiting HIF1A degradation. Cellular & molecular biology letters 29 (1) (2024)
Kaderya Abudusalam, Yan Xu, Pazilat Keyumu, Tong Cheng, Manyu Xu, Bing Lu, Pingping Sun, Kadierjiang Musha, Jianfei Huang
WSCD2 Expression: Its Relevance to Tumor-Infiltrating Immune Cells and Glioma Prognosis. Current medicinal chemistry (2024)
Lei Yang, Jiawen Shi, Mingyang Zhong, Pingping Sun, Xiaojing Zhang, Zhengyi Lian, Hang Yin, Lijun Xu, Guyin He, Haiyan Xu, Han Wu, Ziheng Wang, Kai Miao, Jianfei Huang
NXPH4 mediated by m 5 C contributes to the malignant characteristics of colorectal cancer via inhibiting HIF1A degradation. Cellular & molecular biology letters 29 (1) (2024)
Lili Li, Shumin Hao, Meiling Gao, Junxiao Liu, Xin Xu, Jianfei Huang, Genhong Cheng, Heng Yang
HDAC3 inhibition promotes anti-tumor immunity by enhancing CXCL10 mediated chemotaxis and recruiting of immune cells. Cancer immunology research (2023)
Kadeerjiang Musha, Xinqi Ge, Nuraliya Ablikim, Bing Lu, Chen Chen, Jianfei Huang
Comprehensive Analysis of RELL2 as a Potential Biomarker Associated with Tumor Immune Infiltrating Cells in a Pan-Cancer Analysis. Disease markers 2022 (2022)
Ziheng Wang, Xinqi Ge, Jinlong Shi, Bing Lu, Xiaojin Zhang, Jianfei Huang
SPTSSA Is a Prognostic Marker for Glioblastoma Associated with Tumor-Infiltrating Immune Cells and Oxidative Stress. Oxidative medicine and cellular longevity 2022 (2022)
Tong Cheng, Manyu Xu, Hui Zhang, Bing Lu, Xiaojing Zhang, Ziheng Wang, Jianfei Huang
KLHDC8A Expression in Association with Macrophage Infiltration and Oxidative Stress Predicts Unfavorable Prognosis for Glioma. Oxidative medicine and cellular longevity 2022 (2022)
Xiaoling Kuai, Long Li, Ran Chen, Kangjunjie Wang, Min Chen, Binghai Cui, Yuxue Zhang, Junqiang Li, Hongwen Zhu, Hu Zhou, Jianfei Huang, Jun Qin, Zhiwei Wang, Wenyi Wei, Daming Gao
SCFFBXW7/GSK3β-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells. Cancer research 79 (17) (2019)
Jun Lu, Hengcheng Ma, Shuijin Lian, Dan Huang, Min Lian, Ye Zhang, Jianfei Huang, Xingmei Feng
Clinical Significance and Prognostic Value of the Expression of LAMP3 in Oral Squamous Cell Carcinoma. Disease markers 2017 (2017)

Jianfei Huang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jianfei Huang